Nurix Therapeutics, Inc. (NRIX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.74
Day's range
$15.72

Nurix Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 8.77 M $212.77 M   -1.74% 7.90%
VESTAL POINT CAPITAL, LP 08/14/2026 8.05 M $195.29 M   23.85% 7.25%
DEEP TRACK CAPITAL, LP 08/14/2026 7.74 M $187.69 M   21.93% 6.96%
RUBRIC CAPITAL MANAGEMENT LP 08/14/2026 7.23 M $175.35 M   192.16% 6.51%
FMR LLC 08/13/2026 5.49 M $133.07 M   -1.01% 4.94%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 5.44 M $131.89 M   65.23% 4.89%
MORGAN STANLEY 08/13/2026 4.76 M $115.54 M   -3.44% 4.29%
STATE STREET CORP 08/07/2026 4.68 M $113.47 M   -9.02% 4.21%
BAKER BROS. ADVISORS LP 08/14/2026 4.66 M $113.02 M   0.00% 4.19%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 4.50 M $109.06 M   1.55% 4.05%
PERCEPTIVE ADVISORS LLC 08/14/2026 4.32 M $104.81 M   16.43% 3.89%
REDMILE GROUP, LLC 08/14/2026 4.07 M $98.83 M   -47.32% 3.67%
GENERAL ATLANTIC, L.P. 08/14/2026 3.03 M $73.56 M   -26.08% 2.73%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.54 M $61.57 M   0.68% 2.28%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 2.35 M $57.04 M   -13.75% 2.12%
ARK INVESTMENT MANAGEMENT LLC 08/14/2026 1.79 M $43.50 M   4.19% 1.61%
CAPITAL WORLD INVESTORS 08/12/2026 1.79 M $43.37 M   100.14% 1.61%
TRAILS EDGE CAPITAL PARTNERS, LP 08/14/2026 1.57 M $38.17 M   -9.75% 1.42%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.48 M $35.97 M   34.53% 1.33%
CITADEL ADVISORS LLC 09/02/2026 1.48 M $35.83 M   9.92% 1.33%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 1.47 M $35.54 M   56.17% 1.32%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.43 M $34.72 M   83.34% 1.29%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 1.30 M $31.49 M   0.00% 1.17%
BRAIDWELL LP 08/14/2026 1.29 M $31.22 M   -26.50% 1.16%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 1.19 M $28.98 M   0.00% 1.08%
WOODLINE PARTNERS LP 08/14/2026 1.06 M $25.81 M   14.97% 0.96%
SUMITOMO MITSUI TRUST GROUP, INC. 07/30/2026 983.46 K $23.86 M   -16.74% 0.89%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 08/13/2026 983.46 K $23.85 M   -16.74% 0.89%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 967.62 K $23.47 M   0.00% 0.87%
UBS GROUP AG 08/13/2026 917.12 K $22.25 M   -6.07% 0.83%
NORTHERN TRUST CORP 08/13/2026 876.07 K $21.25 M   2.53% 0.79%
BANK OF AMERICA CORP /DE/ 08/14/2026 842.09 K $20.43 M   4.98% 0.76%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 833.30 K $20.22 M   -9.82% 0.75%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 833.30 K $20.22 M   100.00% 0.75%
NUVEEN, LLC 08/11/2026 825.83 K $20.03 M   1.63% 0.74%
GOLDMAN SACHS GROUP INC 08/14/2026 813.59 K $19.74 M   -38.30% 0.73%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 724.51 K $17.58 M   29.09% 0.65%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 686.34 K $16.65 M   8.56% 0.62%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 08/13/2026 684.25 K $16.60 M   118.26% 0.62%
HANDELSBANKEN FONDER AB 07/10/2026 633.00 K $15.36 M   15.72% 0.57%
RAYMOND JAMES FINANCIAL INC 08/14/2026 593.26 K $14.39 M   67.71% 0.53%
SOFINNOVA INVESTMENTS, INC. 08/14/2026 524.10 K $12.71 M   100.00% 0.47%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 477.14 K $11.58 M   100.00% 0.43%
ELMIND CAPITAL, LP 08/14/2026 460.00 K $11.16 M   0.00% 0.41%
CITIGROUP INC 08/03/2026 389.38 K $9.45 M   -18.44% 0.35%
CANDRIAM S.C.A. 08/13/2026 377.90 K $9.16 M   -29.27% 0.34%
FISHER ASSET MANAGEMENT, LLC 08/04/2026 369.47 K $8.96 M   -3.99% 0.33%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 363.60 K $8.82 M   -41.43% 0.33%
FIRST TRUST ADVISORS LP 08/11/2026 360.85 K $8.75 M   100.00% 0.32%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 340.58 K $8.26 M   52.48% 0.31%

Nurix Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 275 institutional investors and hedge funds held shares of Nurix Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 8.77 M

Vestal Point Capital, LP: 8.05 M

Deep Track Capital, LP: 7.74 M

Rubric Capital Management LP: 7.23 M

FMR LLC: 5.49 M

PRICE T ROWE ASSOCIATES INC /MD/: 5.44 M

106.31% of Nurix Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 141.41 M shares in the last 24 months. This purchase volume represents approximately $2.19 B in transactions.